Protective effects of lactoferrin chimera and bovine lactoferrin in a mouse model of enterohaemorrhagic Escherichia coli O157:H7 infection.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 22332993)

Published in Biochem Cell Biol on February 14, 2012

Authors

Héctor Flores-Villaseñor1, Adrian Canizalez-Román, Jorge Velazquez-Roman, Kamran Nazmi, Jan G M Bolscher, Nidia Leon-Sicairos

Author Affiliations

1: Programa Regional para el Doctorado en Biotecnología, Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Sinaloa, Culiacán Sinaloa, México.

Articles by these authors

The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood (2008) 1.96

Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. Mol Immunol (2012) 1.66

In vitro susceptibility of Burkholderia pseudomallei to antimicrobial peptides. Int J Antimicrob Agents (2009) 1.60

Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily. J Biol Chem (2002) 1.37

Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains. J Biol Chem (2004) 1.26

Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization. Biochem J (2004) 1.14

Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay. FASEB J (2008) 1.13

Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem J (2005) 1.11

Comparative in vivo and in vitro analyses of putative virulence factors of Burkholderia pseudomallei using lipopolysaccharide, capsule and flagellin mutants. FEMS Immunol Med Microbiol (2009) 1.03

Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells. J Control Release (2012) 1.02

Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides (2004) 1.02

Sortase A as a tool for high-yield histatin cyclization. FASEB J (2011) 1.01

Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane. J Biol Chem (2007) 0.99

Preparation of LL-37-grafted titanium surfaces with bactericidal activity. Bioconjug Chem (2006) 0.96

Reactive oxygen species play no role in the candidacidal activity of the salivary antimicrobial peptide histatin 5. Biochem J (2004) 0.93

Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei. Int J Antimicrob Agents (2011) 0.92

Discovery and prevalidation of salivary extracellular microRNA biomarkers panel for the noninvasive detection of benign and malignant parotid gland tumors. Clin Cancer Res (2013) 0.92

Structure-function relationship of the human antimicrobial peptide LL-37 and LL-37 fragments in the modulation of TLR responses. Biol Chem (2009) 0.92

The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans. Biol Chem (2006) 0.91

Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005. Int J Infect Dis (2011) 0.90

The role of salivary histatin and the human cathelicidin LL-37 in wound healing and innate immunity. Biol Chem (2010) 0.90

The influence of oral bacteria on epithelial cell migration in vitro. Mediators Inflamm (2013) 0.87

Structural and biophysical characterization of an antimicrobial peptide chimera comprised of lactoferricin and lactoferrampin. Biochim Biophys Acta (2011) 0.87

A common binding motif for various bacteria of the bacteria-binding peptide SRCRP2 of DMBT1/gp-340/salivary agglutinin. Biol Chem (2008) 0.87

Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry. J Virol (2006) 0.87

Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva. Eur J Oral Sci (2002) 0.86

Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli. Biometals (2010) 0.86

Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides. Biochimie (2008) 0.86

Lactoferrampin, an antimicrobial peptide of bovine lactoferrin, exerts its candidacidal activity by a cluster of positively charged residues at the C-terminus in combination with a helix-facilitating N-terminal part. Biol Chem (2005) 0.85

Structure-activity analysis of histatin, a potent wound healing peptide from human saliva: cyclization of histatin potentiates molar activity 1,000-fold. FASEB J (2009) 0.85

Identification of salivary components that induce transition of hyphae to yeast in Candida albicans. FEMS Yeast Res (2009) 0.83

Sortase-mediated backbone cyclization of proteins and peptides. Biol Chem (2015) 0.83

Microbicidal effect of the lactoferrin peptides lactoferricin17-30, lactoferrampin265-284, and lactoferrin chimera on the parasite Entamoeba histolytica. Biometals (2010) 0.82

Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli. Peptides (2005) 0.82

Lactoferrin-derived antimicrobial peptide induces a micellar cubic phase in a model membrane system. Biophys J (2011) 0.82

Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268-284 and LFampin 265-284: Asp-Leu-Ile makes a difference. Biochem Cell Biol (2006) 0.82

A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin. Peptides (2005) 0.82

Solid-phase synthesis of a pentavalent GalNAc-containing glycopeptide (Tn antigen) representing the nephropathy-associated IgA hinge region. Carbohydr Res (2010) 0.82

Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin. Amino Acids (2012) 0.81

Exoproteome and secretome derived broad spectrum novel drug and vaccine candidates in Vibrio cholerae targeted by Piper betel derived compounds. PLoS One (2013) 0.81

Involvement of the P2X7 purinergic receptor and c-Jun N-terminal and extracellular signal-regulated kinases in cyclooxygenase-2 and prostaglandin E2 induction by LL-37. J Innate Immun (2012) 0.81

A heterodimer comprised of two bovine lactoferrin antimicrobial peptides exhibits powerful bactericidal activity against Burkholderia pseudomallei. World J Microbiol Biotechnol (2013) 0.81

M-CSF priming of osteoclast precursors can cause osteoclastogenesis-insensitivity, which can be prevented and overcome on bone. J Cell Physiol (2015) 0.81

Novel lactoferrampin antimicrobial peptides derived from human lactoferrin. Biochimie (2008) 0.80

Bovine and human lactoferricin peptides: chimeras and new cyclic analogs. Biometals (2014) 0.79

Phytosphingosine kills Candida albicans by disrupting its cell membrane. Biol Chem (2010) 0.79

Structural diversity and mode of action on lipid membranes of three lactoferrin candidacidal peptides. Biochim Biophys Acta (2013) 0.79

Antimicrobial activities of LL-37 and its truncated variants against Burkholderia thailandensis. Int J Antimicrob Agents (2010) 0.79

Influence of specific amino acid side-chains on the antimicrobial activity and structure of bovine lactoferrampin. Biochem Cell Biol (2012) 0.78

Stress as a determinant of saliva-mediated adherence and coadherence of oral and nonoral microorganisms. Psychosom Med (2003) 0.78

Bactericidal effect of lactoferrin and lactoferrin chimera against halophilic Vibrio parahaemolyticus. Biochimie (2008) 0.78

Chimerization of lactoferricin and lactoferrampin peptides strongly potentiates the killing activity against Candida albicans. Biochem Cell Biol (2012) 0.77

Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and the decrease in luxS gene expression by lactoferrin. Biometals (2014) 0.77

C- and N-truncated antimicrobial peptides from LFampin 265 - 284: Biophysical versus microbiology results. J Pharm Bioallied Sci (2011) 0.77

Lactoferrin and lactoferrin chimera inhibit damage caused by enteropathogenic Escherichia coli in HEp-2 cells. Biochimie (2012) 0.77

Covalent RGD modification of the inner pore surface of polycaprolactone scaffolds. J Biomater Sci Polym Ed (2012) 0.77

Identification of the hydroxyapatite-binding domain of salivary agglutinin. Eur J Oral Sci (2013) 0.77

Effect of amino acid substitutions on the candidacidal activity of LFampin 265-284. Peptides (2005) 0.76

Sortase A as a tool to functionalize surfaces. Bioconjug Chem (2013) 0.76

Correction: Human Salivary Micro-RNA in Patients with Parotid Salivary Gland Neoplasms. PLoS One (2016) 0.75

Filling time of a lamellar capillary-filling semen analysis chamber is a rapid, precise, and accurate method to assess viscosity of seminal plasma. J Androl (2007) 0.75

Membrane-active mechanism of LFchimera against Burkholderia pseudomallei and Burkholderia thailandensis. Biometals (2014) 0.75

Vitamin C in plasma and leucocytes in relation to periodontitis. J Clin Periodontol (2012) 0.75

Tailor made plasmin substrates as potential diagnostic tool to test for mastitis. Vet Res Commun (2014) 0.75

Phytosphingosine Prevents the Formation of Young Salivary Biofilms in vitro. Caries Res (2017) 0.75

Sphingoid bases inhibit acid-induced demineralization of hydroxyapatite. Caries Res (2014) 0.75